Netzplantechnik von Küpper, X. Y, Lüder, X. Y, Streitferdt, X. Y

Volltext

Netzplantechnik von Kupper, XY, Luder, XY, Streitferdt, XY

Volltext

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia von Xin, Ying, Jiang, Xin, Wang, Yishu, Su, Xuejin, Sun, Meiyu, Zhang, Lihong, Tan, Yi, Wintergerst, Kupper A, Li, Yan, Li, Yulin

Volltext

674 Analysis of human skin aging and implications for rejuvenating with secreted proteins von Li, L., Arora, R., Wang, Y., Portillo, X., Mintzer, E., Yang, M., Tang, Z., Zheng, Y., Ma, S., Kupper, T., Church, G.

Volltext

Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice von HONG XU, GONZALO, J. A, ST. PIERRE, Y, WILLIAMS, I. R, KUPPER, T. S, COTRAN, R. S, SPRINGER, T. A, GUTIERREZ-RAMOS, J.-C

Volltext

013 Heterogeneous CD4 migratory T cells rapidly and constitutively infiltrate skin and co-exist with populations of resident memory T cells (TRM) von Park, C., Pan, Y., Fu, X., Tian, T., Divito, S., Lin, C., Clark, R., Kupper, T.S.

Volltext

055 Tissue resident memory T cell survival requires exogenous lipid uptake and metabolism von Pan, Y., Tian, T., Park, C., Lofftus, S.Y., Mei, S., Liu, X., Luo, C., O'Malley, J.T., Gehad, A., Teague, J., Divito, S., Fuhlbrigge, R., Puigserver, P., Krueger, J., Hotamisligil, G., Clark, R., Kupper, T.

Volltext

Oral Abstracts 7: RA Clinical O37. Long-Term Outcomes of Early RA Patients Initiated with Adalimumab Plus Methotrexate Compared with Methotrexate Alone Following a Targeted Treatme... von Fleischmann, R., van Vollenhoven, R. F., Smolen, J., Emery, P., Florentinus, S., Rathmann, S., Kupper, H., Kavanaugh, A., Taylor, P., Genovese, M., Keystone, E. C., Drescher, E., Berclaz, P.-Y., Lee, C., Fidelus-Gort, R., Schlichting, D., Beattie, S., Luchi, M., Macias, W., Dikranian, A. H., Alten, R., Klearman, M., Musselman, D., Agarwal, S., Green, J., Gabay, C., Weinblatt, M. E., Schiff, M. H., Valente, R., van der Heijde, D., Citera, G., Zhao, C., Maldonado, M. A., Rakieh, C., Nam, J. L., Hunt, L., Villeneuve, E., Bissell, L.-A., Das, S., Conaghan, P., McGonagle, D., Wakefield, R. J., Wright, H. L., Thomas, H. B., Moots, R., Edwards, S. W., Hamann, P., Heward, J., McHugh, N., Lindsay, M. A., Haroon, M., Giles, J. T., Winchester, R., FitzGerald, O., Karaderi, T., Cohen, C. J., Keidel, S., Appleton, L. H., Macfarlane, G. J., Siebert, S., Evans, D., Paul Wordsworth, B., Plant, D., Bowes, J., Orozco, G., Morgan, A. W., Wilson, A. G., Isaacs, J., Barton, A., Williams, F. M., Livshits, G., Spector, T., MacGregor, A., Scollen, S., Cao, D., Memari, Y., Hyde, C. L., Zhang, B., Sidders, B., Ziemek, D., Shi, Y., Harris, J., Harrow, I., Dougherty, B., Malarstig, A., McEwen, R., Stephens, J. L., Patel, K., Shin, S.-Y., Surdulescu, G., He, W., Jin, X., McMahon, S. B., Soranzo, N., John, S., Wang, J., Spector, T. D., Baker, J., Litherland, G. J., Rowan, A. D.

Volltext

Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis von Nishikawa, M., Owaki, H., Fuji, T., Soliman, M. M., Ashcroft, D. M., Watson, K. D., Lunt, M., Symmons, D., Hyrich, K. L., Atkinson, F., Malik, S., Heycock, C., Saravanan, V., Rynne, M., Hamilton, J., Kelly, C., Burmester, G., Kary, S., Unnebrink, K., Guerette, B., Oezer, U., Kupper, H., Dennison, E., Jameson, K., Hyrich, K., Watson, K., Landewe, R., Keystone, E., Smolen, J., Goldring, M., Patra, K., Cifaldi, M., van der Heijde, D., Lloyd, L. A., Owen, C., Breslin, A., Ahmad, Y., Emery, P., Matteson, E. L., Genovese, M., Sague, S., Hsia, E. C., Doyle, M. K., Fan, H., Elashoff, M., Kirkham, B., Wasco, M. C., Bathon, J., Fleischmann, R., Genovese, M. C., Liu, H., Goldman, J., Leirisalo-Repo, M., Zanetakis, E., El-Kadi, H., Kellner, H., Bolce, R., Wang, J., Dehoratius, R., Decktor, D., Kremer, J., Taylor, P., Mendelsohn, A., Baker, D., Kim, L., Ritchlin, C., Mariette, X., Matucci Cerenic, M., Pavelka, K., van Vollenhoven, R., Heatley, R., Walsh, C., Lawson, R., Reynolds, A., Iaremenko, O., Mikitenko, G., Kavanaugh, A., Luijtens, K., Curtis, J., Schiff, M., Kvien, T., Khanna, D., Furst, D., Behrens, F., Koehm, M., Scharbatke, E. C., Kleinert, S., Weyer, G., Tony, H.-P., Burkhardt, H., Blunn, K. J., Williams, R. B., Young, A., McDowell, J., Weinblatt, M., Haraoui, B., Mozaffarian, N., Khraishi, M., Alten, R., Gomez-Reino, J.

Volltext

Suivi à long terme de l'adalimumab chez des patients français atteints d'une polyarthrite rhumatoïde (PR) : Observatoire ReAlise. Analyse à 24 mois von Mariette, X., Contreras, L., Thibout, E., Kupper, H.

Volltext

Suivi à long terme de l'adalimumab chez des patients français atteints d'une polyarthrite rhumatoïde (PR) : Observatoire ReAlise. Analyse à 18 mois von Mariette, X., Contreras, L., Goldfarb, G., Kupper, H.

Volltext

La co-administration de MTX au cours de la PR augmente significativement la réponse ACR50 à l'adalimumab (Etude ReAct) indépendamment des polymorphismes des gènes MDR1 (multidrug r... von Miceli-Richard, C., Verstuyft, C., Comets, E., Ravaud, P., Kupper, H., Becquemont, L., Mariette, X.

Volltext

Efficacité et tolérance de l'adalimumab chez des patients atteints d'une polyarthrite rhumatoïde (PR) : Résultats finaux chez les 6610 patients de l'Étude ReAct von Mariette, X., Contreras, L., Goldfarb, G., Kupper, H., Burmester, G.-R.

Volltext

Analyse des polymorphismes des gènes des récepteurs FcgIIA, -IIIB et -IIIB comme facteurs prédictifs de la réponse à l'adalimumab (Etude ReAct) au cours de la polyarthrite rhumatoï... von Miceli-Richard, C., Ohresser, M., Comets, E., Goupille, P., Verstuyft, C., Ravaud, P., Kupper, H., Watier, H., Mariette, X.

Volltext

Un haplotype du gène du TNF alpha influence la réponse à l'adalimumab chez les patients atteints de polyarthrite rhumatoïde von Miceli-Richard, C., Comets, E., Verstuyft, C., Loiseau, P., Tamouza, R., Ravaud, P., Kupper, H., Becquemont, L., Charron, P., Mariette, X.

Volltext